VALIDATED EXECUTIVE ENGAGEMENTS
POOL + OUTREACH
8132
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
1138
Interactions with Platform & by Email
PARTICIPANTS
244
Unique # Participated
VALIDATIONS
111
Responses Validated*
* Login to view program details and full enterprise executive list.
DATE
JULY 2020
TABLES
111
PAGES
217
EDITION
15
PRICE
USD $5600
It Pays to Understand the Dynamics of Competition in Your Business Ecosystem.
Who Are Your Competitors in the Prostate Cancer Therapeutics Market?
Amid the COVID-19 crisis, the global market for Prostate Cancer Therapeutics estimated at US$16.1 Billion in the year 2020, is projected to reach a revised size of US$24.8 Billion by 2027, growing at a CAGR of 6.4% over the analysis period 2020-2027. Hormone Therapy, one of the segments analyzed in the report, is projected to record a 6.6% CAGR and reach US$19.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Targeted Therapy segment is readjusted to a revised 6.1% CAGR for the next 7-year period.
The Prostate Cancer Therapeutics market in the U.S. is estimated at US$4.7 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.3 Billion by the year 2027 trailing a CAGR of 6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.1% and 5.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.2% CAGR.
In the global Chemotherapy segment, USA, Canada, Japan, China and Europe will drive the 5.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$853.6 Million in the year 2020 will reach a projected size of US$1.2 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.9 Billion by the year 2027.We bring years of research experience to this 15th edition of our report. The 217-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
AbbVie Inc.; Allergan plc; Amgen Inc.; Astellas Pharma Inc.; AstraZeneca Plc.; Bayer AG; Bristol-Myers Squibb Company; Debiopharm Group; Endo Pharmaceuticals Inc.; F. Hoffmann-La Roche Ltd.; Genentech Inc.; GlaxoSmithKline Plc; Janssen Biotech Inc.; Novartis AG; Pfizer Inc.; Progenics Pharmaceuticals Inc.; Sanofi S.A.; Spectrum Pharmaceuticals Inc.; Takeda Pharmaceutical Company Limited; TOLMAR Pharmaceuticals Inc.
» Therapy Type (Hormone Therapy, Targeted Therapy, Chemotherapy, Other Therapy Types) » Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Sales, Other Distribution Channels)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
INSIDER ACCESS PRIVILEGES
Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.
KEY DIFFERENTIATORS
We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
05
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Impact of Covid-19 and a Looming Global Recession |
| Recent Market Activity |
| An Insight in the Global Market for Prostate Cancer Diagnostics and Therapeutics |
| Rising Incidence of Prostate Cancer: Cornerstone for the Market |
| Current & Future Analysis |
| Developing Countries Turbo Charge Future Market Growth |
| An Insight into the Castration-Resistant Prostate Cancer Therapeutics Market |
| Hormone Therapies to Dominate Global Prostate Cancer Therapeutics Market |
| Key Prostate Cancer Hormone Therapy Drugs & Companies: 2017 |
| Targeted Therapy - The New Frontier of Cancer Treatment |
| Radiotherapy - Gaining Prominence |
| Metastatic Prostate Cancer - Apt for Precision Oncology |
| Launch of Generic Drugs to Place Established Players in Jeopardy |
| Demographics & Lifestyles Raise the Risk of Prostate Cancer |
| Select General Risk Factors and their Relative Risk Rate in Prostate Cancer |
| Small Cap Companies: A Target of Private Capital Financing |
| Cost Analysis of Currently Available Treatment |
| Growth Drivers |
| Growth Restraints |
| Pipeline of Drugs in Clinical Trials |
| Innovations & Advancements |
| Global Competitor Market Shares |
| Prostate Cancer Therapeutics Competitor Market Share Scenario Worldwide (in %): 2018 & 2029 |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| Prostate Cancer Therapeutics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027 |
| Prostate Cancer Therapeutics Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019 |
| Prostate Cancer Therapeutics Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027 |
| Hormone Therapy (Therapy Type) World Market by Region/Country in US$ Million: 2020 to 2027 |
| Hormone Therapy (Therapy Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019 |
| Hormone Therapy (Therapy Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027 |
| Targeted Therapy (Therapy Type) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027 |
| Targeted Therapy (Therapy Type) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019 |
| Targeted Therapy (Therapy Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027 |
| Chemotherapy (Therapy Type) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027 |
| Chemotherapy (Therapy Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019 |
| Chemotherapy (Therapy Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027 |
| Other Therapy Types (Therapy Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027 |
| Other Therapy Types (Therapy Type) Market Historic Review by Region/Country in US$ Million: 2012 to 2019 |
| Other Therapy Types (Therapy Type) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027 |
| Hospital Pharmacies (Distribution Channel) World Market by Region/Country in US$ Million: 2020 to 2027 |
| Hospital Pharmacies (Distribution Channel) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019 |
| Hospital Pharmacies (Distribution Channel) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027 |
| Retail Pharmacies (Distribution Channel) World Market Estimates and Forecasts in US$ Million by Region/Country: 2020 to 2027 |
| Retail Pharmacies (Distribution Channel) Market Worldwide Historic Review by Region/Country in US$ Million: 2012 to 2019 |
| Retail Pharmacies (Distribution Channel) Market Percentage Share Distribution by Region/Country: 2012 VS 2020 VS 2027 |
| Online Sales (Distribution Channel) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2020 to 2027 |
| Online Sales (Distribution Channel) Global Historic Demand in US$ Million by Region/Country: 2012 to 2019 |
| Online Sales (Distribution Channel) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027 |
| Other Distribution Channels (Distribution Channel) World Market by Region/Country in US$ Million: 2020 to 2027 |
| Other Distribution Channels (Distribution Channel) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019 |
| Other Distribution Channels (Distribution Channel) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| United States |
| Market Facts & Figures |
| US Prostate Cancer Therapeutics Market Share (in %) by Company: 2018 & 2025 |
| United States Prostate Cancer Therapeutics Market Estimates and Projections in US$ Million by Therapy Type: 2020 to 2027 |
| Prostate Cancer Therapeutics Market in the United States by Therapy Type: A Historic Review in US$ Million for 2012-2019 |
| United States Prostate Cancer Therapeutics Market Share Breakdown by Therapy Type: 2012 VS 2020 VS 2027 |
| United States Prostate Cancer Therapeutics Market Estimates and Projections in US$ Million by Distribution Channel: 2020 to 2027 |
| Prostate Cancer Therapeutics Market in the United States by Distribution Channel: A Historic Review in US$ Million for 2012-2019 |
| United States Prostate Cancer Therapeutics Market Share Breakdown by Distribution Channel: 2012 VS 2020 VS 2027 |
| Canada |
| Canadian Prostate Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Therapy Type: 2020 to 2027 |
| Canadian Prostate Cancer Therapeutics Historic Market Review by Therapy Type in US$ Million: 2012-2019 |
| Prostate Cancer Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Therapy Type for 2012, 2020, and 2027 |
| Canadian Prostate Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Distribution Channel: 2020 to 2027 |
| Canadian Prostate Cancer Therapeutics Historic Market Review by Distribution Channel in US$ Million: 2012-2019 |
| Prostate Cancer Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Distribution Channel for 2012, 2020, and 2027 |
| Japan |
| Japanese Market for Prostate Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Million by Therapy Type for the Period 2020-2027 |
| Prostate Cancer Therapeutics Market in Japan: Historic Sales Analysis in US$ Million by Therapy Type for the Period 2012-2019 |
| Japanese Prostate Cancer Therapeutics Market Share Analysis by Therapy Type: 2012 VS 2020 VS 2027 |
| Japanese Market for Prostate Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Million by Distribution Channel for the Period 2020-2027 |
| Prostate Cancer Therapeutics Market in Japan: Historic Sales Analysis in US$ Million by Distribution Channel for the Period 2012-2019 |
| Japanese Prostate Cancer Therapeutics Market Share Analysis by Distribution Channel: 2012 VS 2020 VS 2027 |
| China |
| Chinese Prostate Cancer Therapeutics Market Growth Prospects in US$ Million by Therapy Type for the Period 2020-2027 |
| Prostate Cancer Therapeutics Historic Market Analysis in China in US$ Million by Therapy Type: 2012-2019 |
| Chinese Prostate Cancer Therapeutics Market by Therapy Type: Percentage Breakdown of Sales for 2012, 2020, and 2027 |
| Chinese Prostate Cancer Therapeutics Market Growth Prospects in US$ Million by Distribution Channel for the Period 2020-2027 |
| Prostate Cancer Therapeutics Historic Market Analysis in China in US$ Million by Distribution Channel: 2012-2019 |
| Chinese Prostate Cancer Therapeutics Market by Distribution Channel: Percentage Breakdown of Sales for 2012, 2020, and 2027 |
| Europe |
| Market Facts & Figures |
| European Prostate Cancer Therapeutics Market: Competitor Market Share Scenario (in %) for 2018 & 2025 |
| European Prostate Cancer Therapeutics Market Demand Scenario in US$ Million by Region/Country: 2020-2027 |
| Prostate Cancer Therapeutics Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019 |
| European Prostate Cancer Therapeutics Market Share Shift by Region/Country: 2012 VS 2020 VS 2027 |
| European Prostate Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Therapy Type: 2020-2027 |
| Prostate Cancer Therapeutics Market in Europe in US$ Million by Therapy Type: A Historic Review for the Period 2012-2019 |
| European Prostate Cancer Therapeutics Market Share Breakdown by Therapy Type: 2012 VS 2020 VS 2027 |
| European Prostate Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Distribution Channel: 2020-2027 |
| Prostate Cancer Therapeutics Market in Europe in US$ Million by Distribution Channel: A Historic Review for the Period 2012-2019 |
| European Prostate Cancer Therapeutics Market Share Breakdown by Distribution Channel: 2012 VS 2020 VS 2027 |
| France |
| Prostate Cancer Therapeutics Market in France by Therapy Type: Estimates and Projections in US$ Million for the Period 2020-2027 |
| French Prostate Cancer Therapeutics Historic Market Scenario in US$ Million by Therapy Type: 2012-2019 |
| French Prostate Cancer Therapeutics Market Share Analysis by Therapy Type: 2012 VS 2020 VS 2027 |
| Prostate Cancer Therapeutics Market in France by Distribution Channel: Estimates and Projections in US$ Million for the Period 2020-2027 |
| French Prostate Cancer Therapeutics Historic Market Scenario in US$ Million by Distribution Channel: 2012-2019 |
| French Prostate Cancer Therapeutics Market Share Analysis by Distribution Channel: 2012 VS 2020 VS 2027 |
| Germany |
| Prostate Cancer Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Therapy Type for the Period 2020-2027 |
| German Prostate Cancer Therapeutics Historic Market Analysis in US$ Million by Therapy Type: 2012-2019 |
| German Prostate Cancer Therapeutics Market Share Breakdown by Therapy Type: 2012 VS 2020 VS 2027 |
| Prostate Cancer Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Distribution Channel for the Period 2020-2027 |
| German Prostate Cancer Therapeutics Historic Market Analysis in US$ Million by Distribution Channel: 2012-2019 |
| German Prostate Cancer Therapeutics Market Share Breakdown by Distribution Channel: 2012 VS 2020 VS 2027 |
| Italy |
| Italian Prostate Cancer Therapeutics Market Growth Prospects in US$ Million by Therapy Type for the Period 2020-2027 |
| Prostate Cancer Therapeutics Historic Market Analysis in Italy in US$ Million by Therapy Type: 2012-2019 |
| Italian Prostate Cancer Therapeutics Market by Therapy Type: Percentage Breakdown of Sales for 2012, 2020, and 2027 |
| Italian Prostate Cancer Therapeutics Market Growth Prospects in US$ Million by Distribution Channel for the Period 2020-2027 |
| Prostate Cancer Therapeutics Historic Market Analysis in Italy in US$ Million by Distribution Channel: 2012-2019 |
| Italian Prostate Cancer Therapeutics Market by Distribution Channel: Percentage Breakdown of Sales for 2012, 2020, and 2027 |
| United Kingdom |
| United Kingdom Market for Prostate Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Million by Therapy Type for the Period 2020-2027 |
| Prostate Cancer Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Therapy Type for the Period 2012-2019 |
| United Kingdom Prostate Cancer Therapeutics Market Share Analysis by Therapy Type: 2012 VS 2020 VS 2027 |
| United Kingdom Market for Prostate Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Million by Distribution Channel for the Period 2020-2027 |
| Prostate Cancer Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Distribution Channel for the Period 2012-2019 |
| United Kingdom Prostate Cancer Therapeutics Market Share Analysis by Distribution Channel: 2012 VS 2020 VS 2027 |
| Rest of Europe |
| Rest of Europe Prostate Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Therapy Type: 2020-2027 |
| Prostate Cancer Therapeutics Market in Rest of Europe in US$ Million by Therapy Type: A Historic Review for the Period 2012-2019 |
| Rest of Europe Prostate Cancer Therapeutics Market Share Breakdown by Therapy Type: 2012 VS 2020 VS 2027 |
| Rest of Europe Prostate Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Distribution Channel: 2020-2027 |
| Prostate Cancer Therapeutics Market in Rest of Europe in US$ Million by Distribution Channel: A Historic Review for the Period 2012-2019 |
| Rest of Europe Prostate Cancer Therapeutics Market Share Breakdown by Distribution Channel: 2012 VS 2020 VS 2027 |
| Asia-Pacific |
| Prostate Cancer Therapeutics Market in Asia-Pacific by Therapy Type: Estimates and Projections in US$ Million for the Period 2020-2027 |
| Asia-Pacific Prostate Cancer Therapeutics Historic Market Scenario in US$ Million by Therapy Type: 2012-2019 |
| Asia-Pacific Prostate Cancer Therapeutics Market Share Analysis by Therapy Type: 2012 VS 2020 VS 2027 |
| Prostate Cancer Therapeutics Market in Asia-Pacific by Distribution Channel: Estimates and Projections in US$ Million for the Period 2020-2027 |
| Asia-Pacific Prostate Cancer Therapeutics Historic Market Scenario in US$ Million by Distribution Channel: 2012-2019 |
| Asia-Pacific Prostate Cancer Therapeutics Market Share Analysis by Distribution Channel: 2012 VS 2020 VS 2027 |
| Rest of World |
| Rest of World Prostate Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Therapy Type: 2020 to 2027 |
| Rest of World Prostate Cancer Therapeutics Historic Market Review by Therapy Type in US$ Million: 2012-2019 |
| Prostate Cancer Therapeutics Market in Rest of World: Percentage Share Breakdown of Sales by Therapy Type for 2012, 2020, and 2027 |
| Rest of World Prostate Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Distribution Channel: 2020 to 2027 |
| Rest of World Prostate Cancer Therapeutics Historic Market Review by Distribution Channel in US$ Million: 2012-2019 |
| Prostate Cancer Therapeutics Market in Rest of World: Percentage Share Breakdown of Sales by Distribution Channel for 2012, 2020, and 2027 |
| IV. COMPETITION |
| Total Companies Profiled : 81 Click here to request a full table of contents and more details on this project. |
INSIDER ACCESS TO
METHODOLOGY
QUESTIONNAIRE
INFLUENCER NETWORK
Registration is required to access our data stacks.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com